Development of a metabolite calculator for diagnosis of pancreatic cancer
Cancer Medicine · 2023
DOI: 10.1002/cam4.6233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Munseok Choi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin-si, South Korea. Hauptthemen laut MEDLINE: Pancreatic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Industry Development Institute, National Research Foundation of Korea.
Abstract (Originalsprache)
Background
Carbohydrate antigen (CA) 19–9 is a known pancreatic cancer (PC) biomarker, but is not commonly used for general screening due to its low sensitivity and specificity. This study aimed to develop a serum metabolites‐based diagnostic calculator for detecting PC with high accuracy.
Methods
A targeted quantitative approach of direct flow injection‐tandem mass spectrometry combined with liquid chromatography–tandem mass spectrometry was employed for metabolomic analysis of serum samples using an Absolute IDQ™ p180 kit. Integrated metabolomic analysis was performed on 241 pooled or individual serum samples collected from healthy donors and patients from nine disease groups, including chronic pancreatitis, PC, other cancers, and benign diseases. Orthogonal partial least squares discriminant analysis (OPLS‐DA) based on characteristics of 116 serum metabolites distinguished patients with PC from those with other diseases. Sparse partial least squares discriminant analysis (SPLS‐DA) was also performed, incorporating simultaneous dimension reduction and variable selection. Predictive performance between discrimination models was compared using a 2‐by‐2 contingency table of predicted probabilities obtained from the models and actual diagnoses.
Results
Predictive values obtained through OPLS‐DA for accuracy, sensitivity, specificity, balanced accuracy, and area under the receiver operating characteristic curve (AUC) were 0.9825, 0.9916, 0.9870, 0.9866, and 0.9870, respectively. The number of metabolite candidates was narrowed to 76 for SPLS‐DA. The SPLS‐DA‐obtained predictive values for accuracy, sensitivity, specificity, balanced accuracy, and AUC were 0.9773, 0.9649, 0.9832, 0.9741, and 0.9741, respectively.
Conclusions
We successfully developed a 76 metabolome‐based diagnostic panel for detecting PC that demonstrated high diagnostic performance in differentiating PC from other diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin-si, South Korea.
- Department of Information and Statistics, Chungnam National University, Daejeon, South Korea.
- Department of Surgery, CHA Bundang Medical Center, CHA University, South Korea.
- Yonsei Proteome Research Center and Department of Integrated OMICS for Biomedical Science and Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, South Korea.
- Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
- Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
ORCID-Profile: Munseok Choi, Minsu Park
Förderung
- Korea Health Industry Development Institute
- National Research Foundation of Korea
Zitieren
APA
Choi, M., Park, M., Lee, S. H., Lee, M. J., Paik, Y. K., Jang, S. I., Lee, D. K., Lee, S. G., & Kang, C. M. (2023). Development of a metabolite calculator for diagnosis of pancreatic cancer. Cancer Medicine. https://doi.org/10.1002/cam4.6233
Vancouver
Choi M, Park M, Lee SH, Lee MJ, Paik YK, Jang SI, et al. Development of a metabolite calculator for diagnosis of pancreatic cancer. Cancer Medicine. 2023. doi:10.1002/cam4.6233
BibTeX
@article{Choi2023,
author = {Choi, Munseok and Park, Minsu and Lee, Sung Hwan and Lee, Min Jung and Paik, Young-Ki and Jang, Sung Il and Lee, Dong Ki and Lee, Sang-Guk and Kang, Chang Moo},
title = {Development of a metabolite calculator for diagnosis of pancreatic cancer},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.6233}
}
EUVIMED